ID   TOP2A_RAT               Reviewed;        1526 AA.
AC   P41516;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   02-OCT-2024, entry version 198.
DE   RecName: Full=DNA topoisomerase 2-alpha;
DE            EC=5.6.2.2 {ECO:0000255|PROSITE-ProRule:PRU00995};
DE   AltName: Full=DNA topoisomerase II, alpha isozyme;
GN   Name=Top2a; Synonyms=Top-2, Top2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Testis;
RX   PubMed=8390253; DOI=10.1006/bbrc.1993.1694;
RA   Park S.H., Yoon J.H., Kwon Y.D., Park S.D.;
RT   "Nucleotide sequence analysis of the cDNA for rat DNA topoisomerase II.";
RL   Biochem. Biophys. Res. Commun. 193:787-793(1993).
RN   [2]
RP   INTERACTION WITH HNRNPU.
RX   PubMed=20554522; DOI=10.1074/jbc.m110.112979;
RA   Kawano S., Miyaji M., Ichiyasu S., Tsutsui K.M., Tsutsui K.;
RT   "Regulation of DNA Topoisomerase IIbeta through RNA-dependent association
RT   with heterogeneous nuclear ribonucleoprotein U (hnRNP U).";
RL   J. Biol. Chem. 285:26451-26460(2010).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-1210; SER-1328;
RP   SER-1333; THR-1350; SER-1383 AND SER-1387, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Key decatenating enzyme that alters DNA topology by binding
CC       to two double-stranded DNA molecules, generating a double-stranded
CC       break in one of the strands, passing the intact strand through the
CC       broken strand, and religating the broken strand (By similarity). May
CC       play a role in regulating the period length of BMAL1 transcriptional
CC       oscillation (By similarity). {ECO:0000250|UniProtKB:P11388,
CC       ECO:0000250|UniProtKB:Q01320}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP-dependent breakage, passage and rejoining of double-
CC         stranded DNA.; EC=5.6.2.2; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU00995};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00995};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00995};
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00995};
CC       Note=Binds two Mg(2+) per subunit. The magnesium ions form salt bridges
CC       with both the protein and the DNA. Can also accept other divalent metal
CC       cations, such as Mn(2+) or Ca(2+). {ECO:0000255|PROSITE-
CC       ProRule:PRU00995};
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with COPS5 (By
CC       similarity). Interacts with RECQL5; this stimulates DNA decatenation
CC       (By similarity). Interacts with SETMAR; stimulates the topoisomerase
CC       activity (By similarity). Interacts with DHX9; this interaction occurs
CC       in a E2 enzyme UBE2I- and RNA-dependent manner, negatively regulates
CC       DHX9-mediated double-stranded DNA and RNA duplex helicase activity and
CC       stimulates TOP2A-mediated supercoiled DNA relaxation activity (By
CC       similarity). Interacts with HNRNPU (via C-terminus); this interaction
CC       protects the topoisomerase TOP2A from degradation and positively
CC       regulates the relaxation of supercoiled DNA in a RNA-dependent manner
CC       (PubMed:20554522). Interacts with MCM3AP (By similarity). Interacts
CC       with ERCC6 (By similarity). Interacts with PLSCR1 (By similarity).
CC       Interacts with GCNA; this interaction allows the resolution of
CC       topoisomerase II (TOP2A) DNA-protein cross-links (By similarity).
CC       Interacts with POL1RA/RPA1 (via dock II) and UBTF in the context of Pol
CC       I complex; may assist Pol I transcription initiation by releasing
CC       supercoils occurring during DNA unwinding. Interacts with TPRN; TPRN
CC       interacts with a number of DNA damage response proteins, is recruited
CC       to sites of DNA damage and may play a role in DNA damage repair (By
CC       similarity). {ECO:0000250|UniProtKB:P11388,
CC       ECO:0000250|UniProtKB:Q01320, ECO:0000269|PubMed:20554522}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P11388}.
CC       Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P11388}. Nucleus
CC       {ECO:0000250|UniProtKB:P11388}. Nucleus, nucleolus
CC       {ECO:0000250|UniProtKB:P11388}.
CC   -!- PTM: Phosphorylation has no effect on catalytic activity.
CC       {ECO:0000250|UniProtKB:P11388}.
CC   -!- MISCELLANEOUS: Eukaryotic topoisomerase I and II can relax both
CC       negative and positive supercoils, whereas prokaryotic enzymes relax
CC       only negative supercoils.
CC   -!- SIMILARITY: Belongs to the type II topoisomerase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z46372; CAA86496.1; -; mRNA.
DR   EMBL; Z19552; CAA79611.1; -; mRNA.
DR   EMBL; Z29676; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; A48536; A48536.
DR   PIR; JN0598; JN0598.
DR   RefSeq; NP_071519.2; NM_022183.2.
DR   AlphaFoldDB; P41516; -.
DR   SMR; P41516; -.
DR   BioGRID; 261906; 4.
DR   IntAct; P41516; 1.
DR   STRING; 10116.ENSRNOP00000069963; -.
DR   ChEMBL; CHEMBL3400; -.
DR   iPTMnet; P41516; -.
DR   PhosphoSitePlus; P41516; -.
DR   jPOST; P41516; -.
DR   PaxDb; 10116-ENSRNOP00000040257; -.
DR   AGR; RGD:62048; -.
DR   RGD; 62048; Top2a.
DR   eggNOG; KOG0355; Eukaryota.
DR   InParanoid; P41516; -.
DR   OrthoDB; 1944951at2759; -.
DR   PhylomeDB; P41516; -.
DR   BRENDA; 5.6.2.2; 5301.
DR   BRENDA; 5.99.1.3; 5301.
DR   Reactome; R-RNO-4615885; SUMOylation of DNA replication proteins.
DR   PRO; PR:P41516; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005814; C:centriole; ISO:RGD.
DR   GO; GO:0000775; C:chromosome, centromeric region; ISO:RGD.
DR   GO; GO:0000793; C:condensed chromosome; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0009330; C:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex; IDA:RGD.
DR   GO; GO:0001673; C:male germ cell nucleus; ISO:RGD.
DR   GO; GO:0000228; C:nuclear chromosome; ISO:RGD.
DR   GO; GO:0005730; C:nucleolus; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0008094; F:ATP-dependent activity, acting on DNA; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; IDA:RGD.
DR   GO; GO:0003677; F:DNA binding; IDA:RGD.
DR   GO; GO:0008301; F:DNA binding, bending; ISS:UniProtKB.
DR   GO; GO:0003916; F:DNA topoisomerase activity; IDA:RGD.
DR   GO; GO:0003918; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity; IDA:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; ISS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0005080; F:protein kinase C binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0043130; F:ubiquitin binding; ISO:RGD.
DR   GO; GO:0030263; P:apoptotic chromosome condensation; ISO:RGD.
DR   GO; GO:0021707; P:cerebellar granule cell differentiation; IEP:RGD.
DR   GO; GO:0021702; P:cerebellar Purkinje cell differentiation; IEP:RGD.
DR   GO; GO:0030261; P:chromosome condensation; ISO:RGD.
DR   GO; GO:0007059; P:chromosome segregation; ISO:RGD.
DR   GO; GO:0006974; P:DNA damage response; ISO:RGD.
DR   GO; GO:0006266; P:DNA ligation; ISO:RGD.
DR   GO; GO:0006265; P:DNA topological change; IDA:RGD.
DR   GO; GO:0040016; P:embryonic cleavage; ISO:RGD.
DR   GO; GO:0007143; P:female meiotic nuclear division; ISO:RGD.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; ISO:RGD.
DR   GO; GO:1905463; P:negative regulation of DNA duplex unwinding; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0045870; P:positive regulation of single stranded viral RNA replication via double stranded DNA intermediate; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0000712; P:resolution of meiotic recombination intermediates; IBA:GO_Central.
DR   GO; GO:0010212; P:response to ionizing radiation; IEP:RGD.
DR   GO; GO:0071107; P:response to parathyroid hormone; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0000819; P:sister chromatid segregation; IBA:GO_Central.
DR   CDD; cd16930; HATPase_TopII-like; 1.
DR   CDD; cd00187; TOP4c; 1.
DR   CDD; cd03481; TopoIIA_Trans_ScTopoIIA; 1.
DR   CDD; cd03365; TOPRIM_TopoIIA; 1.
DR   Gene3D; 3.30.1360.40; -; 1.
DR   Gene3D; 3.30.1490.30; -; 1.
DR   Gene3D; 3.30.230.10; -; 1.
DR   Gene3D; 3.40.50.670; -; 1.
DR   Gene3D; 3.30.565.10; Histidine kinase-like ATPase, C-terminal domain; 1.
DR   Gene3D; 3.90.199.10; Topoisomerase II, domain 5; 1.
DR   Gene3D; 1.10.268.10; Topoisomerase, domain 3; 1.
DR   InterPro; IPR050634; DNA_Topoisomerase_II.
DR   InterPro; IPR012542; DTHCT.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR020568; Ribosomal_Su5_D2-typ_SF.
DR   InterPro; IPR014721; Ribsml_uS5_D2-typ_fold_subgr.
DR   InterPro; IPR001241; Topo_IIA.
DR   InterPro; IPR013760; Topo_IIA-like_dom_sf.
DR   InterPro; IPR013758; Topo_IIA_A/C_ab.
DR   InterPro; IPR013757; Topo_IIA_A_a_sf.
DR   InterPro; IPR013759; Topo_IIA_B_C.
DR   InterPro; IPR013506; Topo_IIA_bsu_dom2.
DR   InterPro; IPR002205; Topo_IIA_dom_A.
DR   InterPro; IPR001154; TopoII_euk.
DR   InterPro; IPR018522; TopoIIA_CS.
DR   InterPro; IPR031660; TOPRIM_C.
DR   InterPro; IPR006171; TOPRIM_dom.
DR   InterPro; IPR034157; TOPRIM_TopoII.
DR   PANTHER; PTHR10169:SF61; DNA TOPOISOMERASE 2-ALPHA; 1.
DR   PANTHER; PTHR10169; DNA TOPOISOMERASE/GYRASE; 1.
DR   Pfam; PF00204; DNA_gyraseB; 1.
DR   Pfam; PF00521; DNA_topoisoIV; 1.
DR   Pfam; PF08070; DTHCT; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF01751; Toprim; 1.
DR   Pfam; PF16898; TOPRIM_C; 1.
DR   PRINTS; PR01158; TOPISMRASEII.
DR   PRINTS; PR00418; TPI2FAMILY.
DR   SMART; SM00433; TOP2c; 1.
DR   SMART; SM00434; TOP4c; 1.
DR   SUPFAM; SSF55874; ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase; 1.
DR   SUPFAM; SSF54211; Ribosomal protein S5 domain 2-like; 1.
DR   SUPFAM; SSF56719; Type II DNA topoisomerase; 1.
DR   PROSITE; PS52040; TOPO_IIA; 1.
DR   PROSITE; PS00177; TOPOISOMERASE_II; 1.
DR   PROSITE; PS50880; TOPRIM; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Biological rhythms; Cytoplasm; DNA-binding;
KW   Isomerase; Isopeptide bond; Magnesium; Metal-binding; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Topoisomerase;
KW   Ubl conjugation.
FT   CHAIN           1..1526
FT                   /note="DNA topoisomerase 2-alpha"
FT                   /id="PRO_0000145366"
FT   DOMAIN          453..570
FT                   /note="Toprim"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   DOMAIN          713..1168
FT                   /note="Topo IIA-type catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01384"
FT   REGION          340..342
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   REGION          988..997
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   REGION          1087..1120
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1229..1526
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1429..1435
FT                   /note="Interaction with PLSCR1"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   COMPBIAS        1229..1244
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1252..1270
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1286..1304
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1305..1328
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1329..1346
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1364..1378
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1401..1430
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1461..1526
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        803
FT                   /note="O-(5'-phospho-DNA)-tyrosine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01384"
FT   BINDING         90
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   BINDING         118
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   BINDING         146..148
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   BINDING         159..166
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   BINDING         374..376
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   BINDING         459
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   BINDING         539
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   BINDING         539
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   BINDING         541
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   SITE            487
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   SITE            490
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   SITE            659
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   SITE            660
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   SITE            721
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   SITE            755
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   SITE            761
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   SITE            802
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250|UniProtKB:P06786"
FT   SITE            854
FT                   /note="Important for DNA bending; intercalates between base
FT                   pairs of target DNA"
FT                   /evidence="ECO:0000250|UniProtKB:P06786"
FT   SITE            929
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         4
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         280
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1210
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1244
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01320"
FT   MOD_RES         1291
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1293
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1295
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1298
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1323
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01320"
FT   MOD_RES         1328
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1333
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1350
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1370
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1373
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1383
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1387
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1418
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q01320"
FT   MOD_RES         1438
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q01320"
FT   MOD_RES         1465
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1467
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1470
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1472
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1521
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        17
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        154
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        155
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        350
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        384
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        395
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        414
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        416
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        423
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        438
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        464
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        478
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        527
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        582
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        597
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        612
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        620
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        623
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        630
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        637
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        653
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        660
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        674
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1073
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1193
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1201
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1237
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1237
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1272
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1279
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1282
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1359
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1363
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1369
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1381
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1418
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1438
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1450
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1455
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1480
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1488
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
SQ   SEQUENCE   1526 AA;  173221 MW;  A1961ABBDB1B050F CRC64;
     MELSPLQPVN ENMLLNKKKN EDGKKRLSVE RIYQKKTQLE HILLRPDTYI GSVELVTQQM
     WVYDEDVGIN YREVTFVPGL YKIFDEILVN AADNKQRDPK MSCIRVTMMR NNLISIWNNG
     KGIPVVEHKV EKMYVPALIF GQLLTSSNYD DDEKKVTGGR NGYGAKLCNI FSTKFTVETA
     SREYKKMFKQ TWMDNMGRAG DMELKPFSGE DYTCITFQPD LSKFKMQSLD KDIVALMVRR
     AYDIAGSTKD VKVFLNGNRL PVKGFRSYVD MYLKDKVDET GNALKVVHEQ VNPRWEVCLT
     MSEKGFQQIS FVNSIATSKG GRHVDYVADQ IVSKLVDVVK KKNKGGVAVK ADQVKNHMWI
     FGNAVIENPT FDSQTKENMT LQAKSFGSTC QLSEKFIKAA IGCGIVESIL NWVKFKAQIQ
     LNKKCSAVKH NRIKGIPKLD DANDAGSRNS AECTLILTEG DSAKTLAVSG LGVVGRDKYG
     VFPLRGKILN VREASHKQIM ENAEINNIIK IVGLQYKKNY EDEDSLKTLR YGKIMIMTDQ
     DQDGSHIKGL LINFIHHNWP SLLRHRFLEE FITPIVKVSK NKQEIAFYSL PEFEEWKSTN
     PNHKKWKVKY YKGLGTSTSK EAKEYFANMK RHRIQFKYSG PEDDAAISLA FSKKQVDDRK
     EWLTNFMEDR RQRKLLGLPE DYLYGQTTMY LTYNDFINKE LILFSNSDNE RSIPSMVDGL
     KPGQRKVLFT CFKRNDKREV KVAQLAGSVA EMSSYHHGEM SLMMTIINLA QNFVGSNNLN
     LLQPIGQFGT RLHGGKDSAS PRYIFTMLSP LARLLFPSKD DHTLRFLYDD NQRVEPEWYI
     PIIPMVLING AEGIGTGWSC KIPNFDVREV VNNIRRLLDG EEPLPMLPSY KNYKGTIEEL
     ASNQYVINGE VAILNSTTIE ITELPIRTWT QTYKEQVLEP MLNGTEKTPP LITDYREYHT
     DTTVKFVIKM TEEKLAEAER VGLHKVFKLQ TSLTCNSMVL FDHVGCLKKY DTVLDILRDF
     FELRLKYYGL RKEWLLGMLG AESSKLNNQA RFILEKIDGK IVIENKPKKE LIKVLIQRGY
     DSDPVKAWKE AQQKVPEEEE NEENEESESE STSPAAESGP TFNYLLDMPL WYLTKEKKDE
     LCKQRDEKEQ ELNTLKKKTP SDLWKEDLAA FVEELEVVEA KEKQDEQVGL PGKGVKAKGK
     KAQISEVLPS PVGKRVIPQV TMEMRAEAEK KIRRKIKSEN VEGTPAEDGA EPGLRQRLEK
     RQKREPGTRA KKQTTLPFKP IKKAQKQNPW SDSESDMSSN ESNFDVPPRE KEPRIAATKA
     KFTADLDSDD DFSGLDEKDE DEDFFPLDDT PPKTKMPPKN TKKALKPQKS STSVDLESDG
     KDSVPASPGA SAADVPAETE PSKPSSKQTV GVKRTITKGQ SLTSTAGTKK RAVPKETKSD
     SALNAHVSKK PAPAKAKNSR KRMPSSSDSS DSEFEKAISK GATSKKLKGE ERDFHVDLDD
     TVAPRAKSGR ARKPIKYLEE SDDDLF
//
